All of the participants were unplanned ICU admissions suffering from at least one organ dysfunction involving the respiratory system, cardiovascular system, or the kidneys, who were hospitalized between November 22, 2022, and August 30, 2023
It's also being explored for other skin and light-sensitivity conditions
This 72-week, open-label trial randomized 751 participants with obesity or overweight (without T2D) to receive the maximum tolerated dose of either drug
At LIVation, we charge a flat rate at the lowest possible price for semaglutide with the goal of making this revolutionary treatment accessible to as many patients as possible
These conditions can create metabolic resistance that no amount of dietary discipline or exercise intensity can fully overcome without targeted medical treatment
"I think it's OK to not be OK